Conference Description

November 17, 2007
Cleveland Clinic Florida
Jagelman Conference Center
2950 Cleveland Clinic Blvd.
Weston, FL

Tell a friend about this conference

Download the brochure for this conference

CME Credits: 7.5*

Nonrefundable registration fee: $0.

Target Audience: This activity is for pulmonologists, hospitalists, and other health care providers who treat patients with pulmonary diseases.

Program Summary:

The focus of this CME activity is to provide an update in the prevention, diagnosis, and management of pulmonary disease to pulmonologists, hospitalists, and other health providers who treat patients with pulmonary diseases. Current findings in pulmonary research in such topics as COPD, diagnosis and staging of lung cancer, idiopathic pulmonary fibrosis, lung transplantation, allergies and asthma, empyema, and sleep disorders will be presented. Clinicians will benefit from learning new research findings that could lead to improved patient care and safety.

Learning Objectives:
At the conclusion of this program, participants should be able to:

1. Discuss and apply recent advances in the diagnosis and management of Alpha-one Anti-trypsin deficiency
2. Discuss and apply the current approach to the management of COPD
3. Describe the role of endoscopic ultrasonography in the diagnosis and staging of lung cancer
4. Describe the diagnosis and management of pulmonary hypertension
5. List new guidelines in the management of patients with pulmonary fibrosis
6. Discuss current criteria for transplant referrals
7. Discuss current management of difficult to treat asthma
8. Discuss current management of empyema
9. Describe the difference between Restless Leg Syndrome and Periodic Leg Movement disorder

Agenda:
Saturday, November 17, 2007

7:30-7:50 am		Continental Breakfast and Registration
7:50-8:00		Welcome Remarks Franck Rahaghi, MD, MHS
8:00-8:50		Alpha-1 Antitirypsin Deficiency: State Of The Art James Stoller, MD, MS
8:50-9:40		COPD: Difficult to Manage Patients Adam Wanner, MD
9:40-10:10		Break
10:10-11:00		The Role of Endoscopic Ultrasonography in the Diagnosis and Staging of Lung Cancer Eduardo Oliveira, MD
11:00-11:50		Diagnosis and Management of Patients with “Secondary” Pulmonary Hypertension (COPD/Sarcoidosis/IPF, etc.) Franck Rahaghi, MD, MHS
11:50-1:00		Lunch
1:00-1:50		Idiopathic Pulmonary Fibrosis: When To Biopsy, When To Treat Marvin I. Schwarz, MD
1:50-2:40		Lung Transplants: Who To Refer And When? Interactive, Case-Based Presentation Shirin Shafazand, MD, MS
2:40-3:00		Break
3:00-3:50		Allergies and Asthma: When Other Therapies Fail To Work Interactive, Case-Based Presentation Frank Eidelman, MD
3:50-4:40		Management of Empyema Richard I. Light, MD
4:40-5:20		Periodic Leg Movement vs. Restless Leg Syndrome Laurence Smolley, MD
5:20-5:30		Closing Remarks Franck Rahaghi, MD, MHS

Faculty:
Frank Eidelman, MD
Chair, Department of Allergy and Immunology
Cleveland Clinic Florida, Weston, FL

Richard I. Light, MD
Author of Diseases of the Pleura, now in its 5th edition

Eduardo Oliveira, MD
Chariman, Department of Medicine
Director of the Interventional Pulmonology Program
Cleveland Clinic Florida, Weston, FL

Franck Rahaghi, MD, MHS
Director, Pulmonary Hypertension Clinic
Director, Pulmonary Education and Rehabilitation
Cleveland Clinic Florida, Weston, FL

Marvin I. Schwarz, MD
Professor of Medicine and Division Co-Head, Division of Pulmonary Sciences and Critical Care Medicine
University of Colorado
Health Sciences Center
Denver, CO
Co-editor of Interstitial Lung Diseases

Shirin Shafazand, MD, MS
Assistant Professor of Medicine
Assistant Director, Transplant Clinic
University of Miami, Miami, FL

Laurence Smolley, MD
Chair, Department of Pulmonary and Critical Care
Medical Director of the Sleep Disorder Center
Cleveland Clinic Florida, Weston, FL

James Stoller, MD, MS
Professor of Medicine, Cleveland Clinic
Lerner College of Medicine
Vice Chair of Medicine
Cleveland Clinic, Cleveland, OH

Adam Wanner, MD
Professor of Medicine
Joseph Weintraub Professor of Medicine,
Pediatrics and Biomedical Engineering,
University of Miami, Miami, FL
Past president of ATS

Course Director: Franck Rahaghi, MD, MHS

Activity Director: Michelle Frisch, MPH

*Continuing Education Information
This activity has been reviewed and is acceptable for up to 7.5 Prescribed credit(s) by the American Academy of Family Physicians. The AAFP invites comments on any activity that has been approved for AAFP CME credit. Please forward your comments on the quality of this activity to cmecomment@aafp.org.

This activity has been planned and implemented in accordance with the Essentials Areas and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of the University of Massachusetts Medical School (UMMS) and the National Association for Continuing Education. The University of Massachusetts Medical School is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. The University of Massachusetts Medical School designates this continuing medical education activity for a maximum of 7.5 AMA PRA Category I Credit(s)TM. Physicians should only claim credit commensurate with the extent of their participation in the activity.

This offering meets the requirements for 7.5 contact hours for nurses, as specified by the Massachusetts Board of Registration in Nursing (244- CMR 5.04). Each nurse should claim only those hours of credit that he/she actually spent in the educational activity.

Policy on Faculty and Provider Disclosure: It is the policy of the University of Massachusetts Medical School to ensure fair balance, independence, objectivity and scientific rigor in all activities. All faculty participating in CME activities sponsored by the University of Massachusetts Medical School are required to present evidenced- based data, identify and reference off-label product use and disclose all relevant financial relationships with those supporting the activity or others whose products or services are discussed. Faculty disclosure will be provided in the activity materials.

This program was supported through educational grants from the following companies: Actelion, Baxter, Boehringer Ingelheim, CSL Behring, Genentech, Gilead, Schering-Plough, United Therapeutics.